相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Treatment of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with intravenous immunoglobulin in a patient with multiple sclerosis treated with fingolimod after discontinuation of natalizumab
Z. Calic et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2015)
Sodium intake is associated with increased disease activity in multiple sclerosis
Mauricio F. Farez et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Modifiable environmental factors in multiple sclerosis
Yara Dadalti Fragoso
ARQUIVOS DE NEURO-PSIQUIATRIA (2014)
BG-12 (dimethyl fumarate): a review of mechanism of action, efficacy, and safety
Robert J. Fox et al.
CURRENT MEDICAL RESEARCH AND OPINION (2014)
The diagnosis of multiple sclerosis and the various related demyelinating syndromes: A critical review
Dimitrios Karussis
JOURNAL OF AUTOIMMUNITY (2014)
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial
Christian Confavreux et al.
LANCET NEUROLOGY (2014)
Defining the clinical course of multiple sclerosis The 2013 revisions
Fred D. Lublin et al.
NEUROLOGY (2014)
Environmental factors in multiple sclerosis
Alberto Ascherio
EXPERT REVIEW OF NEUROTHERAPEUTICS (2013)
Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1
Chuan Wu et al.
NATURE (2013)
Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells
Markus Kleinewietfeld et al.
NATURE (2013)
Disability in multiple sclerosis A reference for patients and clinicians
Ilya Kister et al.
NEUROLOGY (2013)
Treatment of Acute Relapses in Multiple Sclerosis
Regina Berkovich
NEUROTHERAPEUTICS (2013)
PML in a Patient Treated with Dimethyl Fumarate from a Compounding Pharmacy
Bob W. van Oosten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
PML in a Patient Treated with Fumaric Acid
Ummehan Ermis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Pathology of Demyelinating Diseases
Bogdan F. Gh. Popescu et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 7 (2012)
Immune-mediated CNS diseases: A review on nosological classification and clinical features
Uwe K. Zettl et al.
AUTOIMMUNITY REVIEWS (2012)
Sudden unexpected death on fingolimod
J. W. Lindsey et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Fingolimod for Multiple Sclerosis
Daniel Pelletier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
Robert J. Fox et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Ralf Gold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
Gary Bloomgren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Smoking: effects on multiple sclerosis susceptibility and disease progression
Dean M. Wingerchuk
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2012)
Pathophysiology of multiple sclerosis and the place of teriflunomide
R. Gold et al.
ACTA NEUROLOGICA SCANDINAVICA (2011)
Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
Chris H. Polman et al.
ANNALS OF NEUROLOGY (2011)
Environmental factors in early childhood are associated with multiple sclerosis: a case-control study
Silja Conradi et al.
BMC NEUROLOGY (2011)
Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
Ralf A. Linker et al.
BRAIN (2011)
Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
Owain W. Howell et al.
BRAIN (2011)
Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis
Steve Simpson et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Stephen Sawcer et al.
NATURE (2011)
Inflammatory Cortical Demyelination in Early Multiple Sclerosis
Claudia F. Lucchinetti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
Paul O'Connor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm
Helena Batoulis et al.
ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER (2010)
Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis
Amer Awad et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Vitamin D and multiple sclerosis
Alberto Ascherio et al.
LANCET NEUROLOGY (2010)
Rituximab add-on therapy for breakthrough relapsing multiple sclerosis - A 52-week phase II trial
R. T. Naismith et al.
NEUROLOGY (2010)
MRI criteria for MS in patients with clinically isolated syndromes
X. Montalban et al.
NEUROLOGY (2010)
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
Ludwig Kappos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
Jeffrey A. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Immunomodulatory effects of Vitamin D in multiple sclerosis
Jorge Correale et al.
BRAIN (2009)
The relation between inflammation and neurodegeneration in multiple sclerosis brains
Josa M. Frischer et al.
BRAIN (2009)
Primary-progressive multiple sclerosis (vol 6, pg 903, 2007)
D. Miller et al.
LANCET NEUROLOGY (2009)
Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis
John S. Tzartos et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis
C. F. Lucchinetti et al.
BRAIN (2008)
Grey matter pathology in multiple sclerosis
Jeroen J. G. Geurts et al.
LANCET NEUROLOGY (2008)
Genetics and natural history of multiple sclerosis
Orhun H. Kantarci
SEMINARS IN NEUROLOGY (2008)
Primary-progressive multiple sclerosis
David H. Miller et al.
LANCET NEUROLOGY (2007)
Risk alleles for multiple sclerosis identified by a genomewide study
David A. Hafler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
MR1 criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study
Josephine K. Swanton et al.
LANCET NEUROLOGY (2007)
Natalizumab for multiple sclerosis
Richard M. Ransohoff
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Glatiramer acetate in multiple sclerosis: A review
Maddalena Ruggieri et al.
CNS DRUG REVIEWS (2007)
Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors
Alberto Ascherio et al.
ANNALS OF NEUROLOGY (2007)
Environmental risk factors for multiple sclerosis. Part I: The role of infection
Alberto Ascherio et al.
ANNALS OF NEUROLOGY (2007)
Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis
Kassandra L. Munger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Sex ratio of multiple sclerosis in Canada: a longitudinal study
Sarah-Michelle Orton et al.
LANCET NEUROLOGY (2006)
Oligoclonal bands in multiple sclerosis cerebrospinal fluid: An update on methodology and clinical usefulness
Hans Link et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research
Ralf Gold et al.
BRAIN (2006)
Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes
J. K. Swanton et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
Management of worsening multiple sclerosis with mitoxantrone: A review
EJ Fox
CLINICAL THERAPEUTICS (2006)
Medical progress: Multiple sclerosis - The plaque and its pathogenesis
EM Frohman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy
TA Yousry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Is inflammation important in early PPMS? a longitudinal MRI study
GT Ingle et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Tissue preconditioning may explain concentric lesions in Balo's type of multiple sclerosis
C Stadelmann et al.
BRAIN (2005)
Clinically isolated syndromes suggestive of multiple sclerosis, part 1: natural history, pathogenesis, diagnosis, and prognosis
D Miller et al.
LANCET NEUROLOGY (2005)
Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion
MH Barnett et al.
ANNALS OF NEUROLOGY (2004)
Vitamin D intake and incidence of multiple sclerosis
KL Munger et al.
NEUROLOGY (2004)
Interferon beta-1b in secondary progressive MS - A combined analysis of the two trials
L Kappos et al.
NEUROLOGY (2004)
Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000
WT Mayr et al.
NEUROLOGY (2003)
Remyelinated lesions in multiple sclerosis -: Magnetic resonance image appearance
F Barkhof et al.
ARCHIVES OF NEUROLOGY (2003)
Does the hygiene hypothesis provide an explanation for the high prevalence of multiple sclerosis in Sardinia?
S Stefano et al.
AUTOIMMUNITY (2003)
HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course
LF Barcellos et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
A controlled trial of natalizumab for relapsing multiple sclerosis.
DH Miller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Thalamic neurodegeneration in multiple sclerosis
A Cifelli et al.
ANNALS OF NEUROLOGY (2002)
Mechanisms of action of interferons and glatiramer acetate in multiple sclerosis
S Dhib-Jalbut
NEUROLOGY (2002)
New concepts in the immunopathogenesis of multiple sclerosis
B Hemmer et al.
NATURE REVIEWS NEUROSCIENCE (2002)
Immunopathology of secondary-progressive multiple sclerosis
JW Prineas et al.
ANNALS OF NEUROLOGY (2001)
The neuroimmunology of multiple sclerosis: Possible roles of T and B lymphocytes in immunopathogenesis
KC O'Connor et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2001)
Mechanisms of immunomodulation by glatiramer acetate
B Gran et al.
NEUROLOGY (2000)
分享论文
